Pharmacogenetics and interstitial lung disease Review uri icon

Overview

MeSH Major

  • Intracellular Signaling Peptides and Proteins
  • Lung Diseases, Interstitial

abstract

  • Though few pharmacogenetic investigations have been conducted in patients with ILD to date, ample opportunities for pharmacogenetic exploration exist in this patient population. Such exploration will advance our understanding of specific ILDs and help usher in an era of personalized medicine.

publication date

  • May 31, 2016

Research

keywords

  • Review

Identity

Language

  • eng

PubMed Central ID

  • PMC5004343

Digital Object Identifier (DOI)

  • 10.1097/MCP.0000000000000289

PubMed ID

  • 27253772

Additional Document Info